Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Histone Deacetylases. Found 7 abstracts

Galloway TJ, Wirth LJ, Colevas AD, Gilbert J, Bauman JE, Saba NF, Raben D, Mehra R, Ma AW, Atoyan R, Wang J, Burtness B, Jimeno A. A Phase I Study of CUDC-101, a Multitarget Inhibitor of HDACs, EGFR, and HER2, in Combination with Chemoradiation in Patients with Head and Neck Squamous Cell Carcinoma. Clin Cancer Res. 2015 Apr;21(7):1566-73.
Tu Y, Hershman DL, Bhalla K, Fiskus W, Pellegrino CM, Andreopoulou E, Makower D, Kalinsky K, Fehn K, Fineberg S, Negassa A, Montgomery LL, Wiechmann LS, Alpaugh RK, Huang M, Sparano JA. A phase I-II study of the histone deacetylase inhibitor vorinostat plus sequential weekly paclitaxel and doxorubicin-cyclophosphamide in locally advanced breast cancer. Breast Cancer Res Treat. 2014 Jul;146(1):145-52.
Plotnikova OV, Nikonova AS, Loskutov YV, Kozyulina PY, Pugacheva EN, Golemis EA. Calmodulin activation of Aurora-A kinase (AURKA) is required during ciliary disassembly and in mitosis. Mol Biol Cell. 2012 Jul;23(14):2658-70.   PMCID: PMC3395655
Poleshko A, Palagin I, Zhang R, Boimel P, Castagna C, Adams PD, Skalka AM, Katz RA. Identification of cellular proteins that maintain retroviral epigenetic silencing: evidence for an antiviral response. J Virol. 2008 Mar;82(5):2313-23.   PMCID: PMC2258957
Katz RA, Jack-Scott E, Narezkina A, Palagin I, Boimel P, Kulkosky J, Nicolas E, Greger JG, Skalka AM. High Frequency Epigenetic Repression and Silencing of Retroviruses can be Antagonized by HDAC Inhibitors and Transcriptional Activators, but Uniform Reactivation in Cell Clones is Restricted by Additional Mechanisms. J Virol. 2007 Jan 03;81(6):2592-604.
Pugacheva EN, Jablonski SA, Hartman TR, Henske EP, Golemis EA. HEF1-dependent Aurora A activation induces disassembly of the primary cilium.[see comment]. Cell. 2007 Jun 29;129(7):1351-63.
Koumenis C, Alarcon R, Hammond E, Sutphin P, Hoffman W, Murphy M, Derr J, Taya Y, Lowe SW, Kastan M, Giaccia A. Regulation of p53 by hypoxia: dissociation of transcriptional repression and apoptosis from p53-dependent transactivation. Mol Cell Biol. 2001 Feb;21(4):1297-310.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Histone Deacetylases

Histone Deacetylases genetics antagonists & inhibitors metabolism Signal Transducing Adaptor Proteins Phosphorylation physiology Signal Transduction Hydroxamic Acids Cell Line Enzyme Inhibitors Genetic Epigenesis adverse effects Retroviridae Hela Cells Protein-Serine-Threonine Kinases Female Aged Mitosis therapeutic use Middle Aged Gene Silencing administration & dosage Cilia Small Interfering RNA Phosphoproteins Messenger RNA Biological Models Drug Administration Schedule Base Sequence Paclitaxel therapy human) 0 (NEDD9 protein Protein Binding Reverse Transcriptase Polymerase Chain Reaction Squamous Cell Carcinoma Maximum Tolerated Dose Treatment Outcome Point Mutation Adult Non-Histone Chromosomal Proteins Protein p53 drug effects Chemoradiotherapy Cell Hypoxia EC 3-5-1 (Histone Deacetylases) 0 (Phosphoproteins) Genetic Promoter Regions Gene Expression pharmacology ErbB-2 Receptor Cytokinesis methods Epidermal Growth Factor Receptor ul [Ultrastructure] US Gov't Support-PHS Head and Neck Neoplasms Male Radiotherapy ge [Genetics] Reporter Genes Cell Nucleus me [Metabolism] Human Quinazolines EC 2-7-1 (aurora kinase) RNA Interference Antineoplastic Agents Proteins Apoptosis Centrosome pd [Pharmacology] Acetylation de [Drug Effects] Phorbol Esters Antineoplastic Combined Chemotherapy Protocols Cyclin-Dependent Kinase Inhibitor p27 Proto-Oncogene Proteins Trans-Activators Cell Cycle Clone Cells Non-US Gov't Support EC 2-7-1-37 (Protein-Serine-Threonine Kinases) Nuclear Proteins Enzyme Activation chemistry Ki-67 Antigen Calcium Doxorubicin human) EC 3-5-1 (HDAC6 protein Green Fluorescent Proteins Cisplatin Molecular Models Calmodulin Breast Neoplasms DNA Primers drug therapy pathology Neoplasm Staging Neoplastic Cell Transformation ph [Physiology] 0 (Enzyme Inhibitors) Binding Sites Trans-Activation (Genetics) Cyclophosphamide p53 Genes Signal Transducing) 0 (Adaptor Proteins ai [Antagonists & Inhibitors] Tumor Biomarkers DNA Damage Genetic Vectors Cyclin-Dependent Kinase Inhibitor p21
Last updated on Friday, January 03, 2020